The metabolic paradox of aripiprazole: Weight-neutral in monotherapy but weight-reducing as adjunctive therapy

Antipsychotic-induced metabolic dysfunction affects 37–63% of patients, contributing to reduced life expectancy in serious mental illness. Aripiprazole demonstrates a differential effect being weight-neutral in monotherapy but producing substantial weight reduction when combined with clozapine. This...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Madhurima Dhar, Jigyansa Ipsita Pattnaik, Jayaprakash Russell Ravan, Udit Kumar Panda, Pallavi Preetinanda, Sudipta Kumar Das
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wolters Kluwer Medknow Publications 2026-01-01
Schriftenreihe:	Industrial Psychiatry Journal
Schlagworte:	antipsychotic polypharmacy aripiprazole clozapine drug combination therapy metabolic side effects metabolic syndrome psychiatric pharmacotherapy psychopharrmacology treatment-resistant schizophrenia weight reduction
Online-Zugang:	https://journals.lww.com/10.4103/ipj.ipj_213_25
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!